Latest Governance News

Page 12 of 860
Ramsay Health Care delivered stronger FY26 earnings, a higher fully franked dividend and improved Funding Group leverage as it prepares to separate Ramsay Santé. The proposed demerger remains conditional, but the company has set a clear timetable for the next phase of its portfolio reshaping.
Ada Torres
Ada Torres
25 Sept 2026
Latrobe Magnesium has moved its demonstration plant into the final installation stage for magnesium metal, but its annual report flags a material uncertainty over whether the loss-making group can continue as a going concern. The company had $1.09 million in cash at 30 June and has since secured an $8.5 million equity raising to fund commissioning and corporate costs.
Victor Sage
Victor Sage
25 Sept 2026
MetalsGrove Mining has expanded its Côte d’Ivoire gold footprint and begun a 10,000-metre auger campaign, but its FY2026 annual report carries a material going-concern uncertainty. The company ended the year with $1.97 million in cash after raising $2.70 million, while exploration commitments due within 12 months total $1.09 million.
Maxwell Dee
Maxwell Dee
25 Sept 2026
Bannerman Energy has completed CNOL’s US$320.4 million strategic investment in the Etango uranium project, giving the joint venture approximately US$303 million in cash and a debt-free construction pathway. The project now moves towards a Final Investment Decision and full-scale construction targeted for Q4 2026.
Maxwell Dee
Maxwell Dee
25 Sept 2026
Tungsten Mining has appointed Jefferies Australia to pursue strategic investors for its Watershed tungsten project, adding a global investment bank to a funding campaign already covering debt, offtake and government support. The move expands the options around a project with a reported A$1.309 billion pre-tax NPV8, but no funding deal or Final Investment Decision has been secured.
Maxwell Dee
Maxwell Dee
25 Sept 2026
Australian Rare Earths has converted Koppamurra from an exploration story into a defined rare earths development case, with an A$858 million after-tax PFS NPV and a maiden Ore Reserve. The next test is less geological than financial: the company must fund the path from pilot processing to construction while carrying a material going-concern warning.
Maxwell Dee
Maxwell Dee
24 Sept 2026
Cobalt Blue has cleared important technical and regulatory hurdles at its Kwinana refinery, but the pre-revenue developer says further funding is needed and auditors flagged material uncertainty over its ability to continue as a going concern. The company reported an A$8.797 million loss for FY2026 despite ending the year with A$4.265 million in cash.
Victor Sage
Victor Sage
24 Sept 2026
Sunshine Metals reduced its annual loss and ended June with $20.6 million in cash, but its auditor flagged a material uncertainty over the company’s ability to continue as a going concern. The warning comes as Sunshine funds the Mt Moss processing conversion, faces a $10 million deferred payment and targets first gold in mid-2027.
Maxwell Dee
Maxwell Dee
24 Sept 2026
Sonic Healthcare delivered a strong FY2026, with underlying net profit up 17% to A$621 million and dividends rising to A$1.08 per share. The next test is whether US efficiencies, LADR synergies and organic growth can offset Swiss fee cuts, a delayed UK contract ramp-up and heavier investment demands.
Ada Torres
Ada Torres
24 Sept 2026
Dataworks Group delivered a much-improved FY26, with revenue up 24%, operating cash flow turning positive and its Ontario platform entering commercial operation. But the ASX-listed regtech company remains loss-making, carries net liabilities of $1.93 million and says its survival depends on further funding.
Sophie Babbage
Sophie Babbage
24 Sept 2026
Immuron delivered record FY26 sales, a narrower loss and a much stronger cash balance, while shifting clinical development towards commercial partners. The annual report also flags a material weakness in inventory controls and confirms that IMM-529 remains dependent on a future licensing deal.
Victor Sage
Victor Sage
24 Sept 2026
VRX Silica has assembled much of the commercial and regulatory case for Arrowsmith North, including 960,000 tonnes per annum of binding offtakes and a reported A$179.2 million project NPV. The harder test now is funding construction while final approvals, logistics contracts and a final investment decision remain outstanding.
Maxwell Dee
Maxwell Dee
24 Sept 2026

Browse the archive

Full archive